The Canadian Bioceutical CBICF

RE:RE:RE:RE:RE:RE:RE:RE:Confused.

[Kmd001]

duediligence123 wrote: Wrong Longdollars, but wouldn't your dream scheme be nice...lol...read the NR again, at time of closing of transaction MPX shareholders will receive 0.1673 shares of Ian for every share of MPX they hold...the 30% value was given to $1.28...now both stocks should start trading on par to the agreement, and MPX shares will increase in price as Ian increases in price...at valuation yesterday, still slight advantage holding MPX, but the values are getting closer...hope you understand

@duediligence:  thank God. someone who can read a news release.  Seems there are a lot of people here who can't and who probbluy shouldn't be trading their own accounts.    For those who keep panicking, read the friggin news release:

The Agreement provides that MPX shareholders will be entitled to receive 0.1673 common shares of iAnthus for each common share of MPX held (the "Exchange Ratio"), representing a consideration of approximately $1.28 per MPX common share, a premium of 30.6% based on the closing price of iAnthus and MPX common shares on October 17, 2018. In addition, each MPX shareholder will receive common shares of the newly formed MPX International which will hold all of the non-U.S. businesses of MPX. MPX International will apply to list on the Canadian Securities Exchange (the "CSE") with the listing to occur contemporaneously with closing of the transaction. All references to currency are in Canadian dollars.

You get .1673 shares of iAnthius for each share of MPX you hold.  If iAnthus goes to 100, you still get .1673 shares of it. if iAnthus goes to $0.05 you still get .1673 shares of it for each MPX share.  THE PRICE OF iANTHUS IS IRRELEVANT to ho many shares you get.

smh